Ignite Creation Date:
2025-12-24 @ 11:19 PM
Ignite Modification Date:
2026-01-18 @ 2:02 PM
Study NCT ID:
NCT00838656
Status:
UNKNOWN
Last Update Posted:
2013-09-17
First Post:
2009-02-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Two Different Schedules of Carboplatin, Paclitaxel, Gemcitabine, and Surgery in Treating Patients With Newly Diagnosed Stage IIIC or Stage IV Primary Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Sponsor:
Warwick Medical School
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
CDR0000632859
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None